IP Library Granted Patent US 8,076,162
Granted Patent B2
US 8,076,162 · App. 12/419,899 · Granted Dec 13, 2011

Method of providing particles having biological-binding areas for biological applications

Assignee: Life Bioscience, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,076,162
App. No.
12/419,899
Granted
Dec 13, 2011
Kind
B2
Abstract

The present invention includes micro-sphere composition, methods of making binding assays. The present invention also includes a micro-sphere for binding biological molecules without pretreatment. The micro-sphere includes a spherical glass substrate having one or more metal nanoparticle regions that are exposed from within the glass, wherein the micro-sphere is capable of binding biological molecules without pretreatment.

Claims (30)

1. A method of providing a bead having discrete binding areas for biological-testing, comprising:

preparing a glass bead substrate by at least one process step selected from the group consisting of

exposing the glass bead to an activating energy source, baking the glass bead having a glass transition temperature at a temperature above the glass transition temperature, etching at least one selected area of the glass bead to expose metal nanoparticles from within the glass, wherein the metal nanoparticles have a range of diameters and are spaced from other metal nanoparticles by an average distance of at least one-half the midpoint of the diameter range, and the metal nanoparticles are less than about 300 nanometers in diameter, whereby the at least one selected area provides a chemistry for increased binding as compared to unselected areas.

2. The method of claim 1 , wherein the metal nanoparticles comprise silver, gold, platinum, rhodium, palladium, nickel, cobalt, and copper, and alloys thereof.

3. The method of claim 1 , wherein the metal nanoparticles comprise oxides of one or more metal oxides selected from silver, gold, and copper, and wherein at least some of the one or more metal oxides are reduced to metal to provide the metal nanoparticles.

4. The method of claim 1 , wherein the glass bead substrate comprises one or more nucleating agents selected from titanium dioxide, tin oxide, ruthenium, rhenium, oxmium iridum, phosphorous pentoxide, Vanadium pentoxide, molybdenum oxides, tungsten oxides, iron oxides, and combinations thereof.

5. The method of claim 1 , wherein the metal nanoparticles that are exposed from within the glass bead are formed by metal-precipitating and then metal-coalescing baking.

6. The method of claim 1 , wherein the areas are exposed to high-energy particles to reduce at least some oxide of at least one of silver, gold, and copper in the areas to metal.

7. The method of claim 1 , wherein the metal nanoparticles are added as metal particles during fabrication of the glass bead substrate.

8. The method of claim 1 , wherein the metal nanoparticles are added as metal salt during fabrication of the glass bead substrate.

9. A substrate for binding biological molecules without pretreatment comprising:

an at least partially spherical glass substrate comprising one or more metal particle regions that are exposed from within the at least partially spherical glass substrate, wherein the substrate is capable of binding biological molecules without pretreatment.

10. The substrate of claim 9 , wherein the one or more metal particle regions comprise silver, gold, platinum, rhodium, palladium, nickel, cobalt, and copper, and alloys thereof.

11. The substrate of claim 9 , wherein the one or more metal particle regions comprise oxides of one or more metal oxides selected from silver, gold, and copper, and wherein at least some of the one or more metal oxides are reduced to metal to provide metal nanoparticles.

12. The substrate of claim 9 , wherein the one or more metal particle regions that are exposed from within the at least partially spherical glass substrate are formed by metal-precipitating and then metal-coalescing baking.

13. The substrate of claim 9 , wherein the one or more metal particle regions are exposed to high-energy particles to reduce at least some oxide of at least one of silver, gold, and copper in the areas to metal.

14. The substrate of claim 9 , wherein the one or more metal particle regions are added as metal particles during fabrication of the glass bead substrate.

15. The substrate of claim 9 , wherein the one or more metal particle regions comprise a metal particle that is generally micrometer or nanometer in diameter.

16. The substrate of claim 9 , wherein the one or more metal particle regions comprise metal nanoparticles, wherein the metal nanoparticles have a range of diameters and are spaced from other metal nanoparticles by an average distance of at least one-half the midpoint of the diameter range, and the metal nanoparticles are less than about 300 nanometers in diameter, whereby the one or more metal particle regions provide a chemistry for increased binding as compared to other areas of the substrate.

17. A micro-sphere binding assay for binding biological molecules without pretreatment comprising:

preparing a glass micro-sphere bead substrate by least one process step selected from the group consisting of exposing the glass micro-sphere bead to an activating energy source, baking the glass micro-sphere bead having a glass transition temperature at a temperature above the glass transition temperature, etching at least one selected area of the glass micro-sphere bead to expose metal nanoparticles from within the glass micro-sphere bead; and depositing patterned areas of biological-binding-glass on a substrate, wherein the metal nanoparticles have a range of diameters and are spaced from other metal nanoparticles by an average distance of at least one-half the midpoint of the diameter range, and the metal nanoparticles are less than about 300 nanometers in diameter, whereby the at least one selected area provides a chemistry for increased binding as compared to unselected areas;

binding one or more biological molecules to the glass micro-sphere bead; and

detecting the presence of the one or more biological molecules.

18. The assay of claim 17 , wherein the metal nanoparticles are used for assay techniques using plasmon excitation of proximal noble metal clusters.

19. The assay of claim 17 , wherein the metal nanoparticles are used for surface enhanced fluorescence SEF, surface enhanced Raman spectroscopy SERS, surface enhanced resonant Raman spectroscopy SERRS, or surface plasmon resonance SPR.

20. The assay of claim 17 , wherein the metal nanoparticles comprise oxides of one or more metal oxides selected from silver, gold, and copper, and wherein at least some of the one or more metal oxides are reduced to metal to provide the metal nanoparticles.

21. The assay of claim 17 , wherein the metal nanoparticles that are exposed from within the glass micro-sphere bead are formed by metal-precipitating and then metal-coalescing baking.

22. The assay of claim 17 , wherein the at least one selected area is exposed to high-energy particles to reduce at least some oxide of at least one of silver, gold, and copper to metal in the at least one selected area.

23. The assay of claim 17 , wherein the metal nanoparticles are added as metal particles during fabrication of the glass micro-sphere bead substrate.

24. The method of claim 17 , wherein the metal nanoparticles are added as metal salt during fabrication of the glass micro-sphere bead substrate.

Assignments (6)
ADDENDUM TO INTELLECTUAL PROPERTY SECURITY AGREEMENT DATED JANUARY 27, 2022 Recorded Mar 4, 2024
From: 3D GLASS SOLUTIONS, INC.
To: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 066729/0512 →
CHANGE OF NAME Recorded Jun 6, 2018
From: LIFE BIOSCIENCE, INC.
To: 3D GLASS SOLUTIONS, INC.
Reel/Frame 046314/0516 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY AND RECEIVING PARTY INFORMATION PREVIOUSLY RECORDED AT REEL: 045877 FRAME: 0300. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 4, 2018
From: TRANCHE2, LLC
To: 3D GLASS SOLUTIONS, INC.
Reel/Frame 047224/0922 →
RELEASE OF SECURITY INTEREST Recorded May 22, 2018
From: 3D GLASS SOLUTIONS, INC.
To: TRANCHE2, LLC
Reel/Frame 045877/0303 →
SECURITY INTEREST Recorded Jan 20, 2016
From: LIFE BIOSCIENCE, INC.
To: TRANCHE2, LLC
Reel/Frame 037539/0047 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2011
From: FLEMMING, JEB H.; BUCKLEY, COLIN T.; SCHMIDT, CARRIE
To: LIFE BIOSCIENCE, INC.
Reel/Frame 025828/0976 →
Continuity (2)
Provisional Application 61043052 · Apr 7, 2008
Related Publication 20090258441A1 · Oct 15, 2009